Attached files
| file | filename |
|---|---|
| EX-10.1 - EXHIBIT 10.1 - NewCardio, Inc. | ex101.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): December 30, 2009
NewCardio,
Inc.
(Exact
name of Company as specified in its charter)
|
Delaware
|
333-149166
|
20-1826789
|
||
|
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification)
|
2350 Mission College
Boulevard, Suite 1175, Santa Clara CA 95054
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (408)
516-5000
N/A
(Former
name or former address, if changed since last report)
|_| Written
communication pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|_| Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|_| Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
40.13e-4(c))
Item
1.01 Entry into a Material Definitive Agreement.
On December 30, 2009, NewCardio, Inc.
(the “Company”) announced that its $3 million credit line was amended to extend
for two months the period during which advances are available under
the credit line and its maturity date.
A copy of
the amendment is filed herewith as Exhibit 10.1.
Item
9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d)
Exhibits
Set forth
below is a list of exhibits to this Current Report on Form 8-K:
|
Exhibit No.:
|
Description:
|
|
|
10.1
|
Amendment
to $3 million Credit Line
|
2
SIGNATURES
Pursuant
to the requirement of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
NewCardio,
Inc.
|
|||
|
Date: December
30, 2009
|
By:
|
/s/ Richard D.
Brounstein
|
|
|
Richard
D. Brounstein
|
|||
|
Chief
Financial Officer
|
|||
3